Synthetic DNA is tomorrow’s medicine

| May 7, 2012
XNA
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

An international team of researchers has created revolutionary proteins that can copy synthetic genetic material – the so-called XNA (Xeno-Nucleic Acids). The breakthrough could pave the way for doctors to start treating diseases with XNA by letting the synthetic genetic material intervene and stop essential processes in the course of a disease.

View the original post here: Synthetic DNA is tomorrow’s medicine

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend